SGN1

· Guangzhou Sinogen Pharmaceutical Co., Ltd

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SGN1, covering 2025-04-30 to 2025-04-30. Get the full timeline:

Most recent: Clinical Trial Update: Study of SGN1 in Patients With Advanced Solid Tumor [Phase 1, Phase 2]